# Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis.

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-and-safety-of-certolizumab-pegol-and-golimumab-in-the-treatment-of-non/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Gian Marco Tosi,Jurgen Sota,Antonio Vitale,Donato Rigante,Giacomo Emmi,Giuseppe Lopalco,Silvana Guerriero,Ida Orlando,Florenzo Iannone,Bruno Frediani,Rossella Angotti,Mario Messina,Mauro Galeazzi,Lorenzo Vannozzi,Luca Cantarini,Claudia Fabiani |
| Citations | 59 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2930965875 |
| PMID | 30943133 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Lorenzo Vannozzi](https://scholariq.org/researchers/lorenzo-vannozzi/)

## Paper journal

- [PubMed](https://scholariq.org/journals/pubmed/)

## Paper primary topic

- [Ocular Diseases and Behçet’s Syndrome](https://scholariq.org/topics/ocular-diseases-and-behcet-s-syndrome/)

## Paper topics

- [Ocular Diseases and Behçet’s Syndrome](https://scholariq.org/topics/ocular-diseases-and-behcet-s-syndrome/)
- [Retinal and Optic Conditions](https://scholariq.org/topics/retinal-and-optic-conditions/)
- [Sarcoidosis and Beryllium Toxicity Research](https://scholariq.org/topics/sarcoidosis-and-beryllium-toxicity-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.